These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 27194019)

  • 1. Adjuvant gemcitabine monotherapy for resectable perihilar cholangiocarcinoma with lymph node involvement: a propensity score matching analysis.
    Mizuno T; Ebata T; Yokoyama Y; Igami T; Sugawara G; Yamaguchi J; Nagino M
    Surg Today; 2017 Feb; 47(2):182-192. PubMed ID: 27194019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant S-1 vs gemcitabine for node-positive perihilar cholangiocarcinoma: A propensity score-adjusted analysis.
    Takahashi D; Mizuno T; Yokoyama Y; Igami T; Yamaguchi J; Onoe S; Watanabe N; Maeda O; Ando M; Ebata T
    J Hepatobiliary Pancreat Sci; 2021 Sep; 28(9):716-726. PubMed ID: 34087061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gemcitabine-based adjuvant chemotherapy improves survival after aggressive surgery for hilar cholangiocarcinoma.
    Murakami Y; Uemura K; Sudo T; Hayashidani Y; Hashimoto Y; Nakamura H; Nakashima A; Sueda T
    J Gastrointest Surg; 2009 Aug; 13(8):1470-9. PubMed ID: 19421824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoadjuvant chemotherapy followed by curative-intent surgery for perihilar cholangiocarcinoma based on its anatomical resectability classification and lymph node status.
    Kuriyama N; Usui M; Gyoten K; Hayasaki A; Fujii T; Iizawa Y; Kato H; Murata Y; Tanemura A; Kishiwada M; Sakurai H; Mizuno S; Isaji S
    BMC Cancer; 2020 May; 20(1):405. PubMed ID: 32393197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant radiotherapy and chemotherapy offer a recurrence and survival benefit in patients with resected perihilar cholangiocarcinoma.
    Im JH; Choi GH; Lee WJ; Han DH; Park SW; Bang S; Choi HJ; Seong J
    J Cancer Res Clin Oncol; 2021 Aug; 147(8):2435-2445. PubMed ID: 33471185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Verification of the oncologic inferiority of percutaneous biliary drainage to endoscopic drainage: A propensity score matching analysis of resectable perihilar cholangiocarcinoma.
    Komaya K; Ebata T; Yokoyama Y; Igami T; Sugawara G; Mizuno T; Yamaguchi J; Nagino M
    Surgery; 2017 Feb; 161(2):394-404. PubMed ID: 27712872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiotherapy or Chemoradiation in Unresectable Biliary Cancer: A Retrospective Study.
    Bisello S; Buwenge M; Palloni A; Autorino R; Cellini F; Macchia G; Deodato F; Cilla S; Brandi G; Tagliaferri L; Cammelli S; Valentini V; Morganti AG; Mattiucci GC
    Anticancer Res; 2019 Jun; 39(6):3095-3100. PubMed ID: 31177154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A retrospective analysis of the clinical effects of neoadjuvant combination therapy with full-dose gemcitabine and radiation therapy in patients with biliary tract cancer.
    Kobayashi S; Tomokuni A; Gotoh K; Takahashi H; Akita H; Marubashi S; Yamada T; Teshima T; Fukui K; Fujiwara Y; Sakon M
    Eur J Surg Oncol; 2017 Apr; 43(4):763-771. PubMed ID: 28100416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concomitant hepatic artery resection for advanced perihilar cholangiocarcinoma: a case-control study with propensity score matching.
    Noji T; Tsuchikawa T; Okamura K; Tanaka K; Nakanishi Y; Asano T; Nakamura T; Shichinohe T; Hirano S
    J Hepatobiliary Pancreat Sci; 2016 Jul; 23(7):442-8. PubMed ID: 27207604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival Outcomes of Gemcitabine Plus S-1 Adjuvant Chemotherapy after Surgical Resection for Advanced Biliary Tract Cancer.
    Hosoda K; Fukushima K; Shimizu A; Motoyama H; Kubota K; Notake T; Sugenoya S; Hayashi H; Yasukawa K; Kobayashi R; Soejima Y
    Oncology; 2021; 99(11):703-712. PubMed ID: 34515195
    [TBL] [Abstract][Full Text] [Related]  

  • 11.  Intrahepatic, perihilar and distal cholangiocarcinoma: Management and outcomes.
    Waseem D; Tushar P
    Ann Hepatol; 2017 Jan-Feb 2017; 16(1):133-139. PubMed ID: 28051802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors after surgical resection for intrahepatic, hilar, and distal cholangiocarcinoma.
    Murakami Y; Uemura K; Sudo T; Hashimoto Y; Nakashima A; Kondo N; Sakabe R; Ohge H; Sueda T
    Ann Surg Oncol; 2011 Mar; 18(3):651-8. PubMed ID: 20945107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current Management of Perihilar Cholangiocarcinoma and Future Perspectives.
    Lewis HL; Rahnemai-Azar AA; Dillhoff M; Schmidt CR; Pawlik TM
    Chirurgia (Bucur); 2017; 112(3):193-207. PubMed ID: 28675356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in Prognostic Factors and Recurrence Patterns After Curative-Intent Resection of Perihilar and Distal Cholangiocarcinomas.
    Sallinen V; Sirén J; Mäkisalo H; Lehtimäki TE; Lantto E; Kokkola A; Nordin A
    Scand J Surg; 2020 Sep; 109(3):219-227. PubMed ID: 30791825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant Therapy Is Associated With Improved Survival in Resected Perihilar Cholangiocarcinoma: A Propensity Matched Study.
    Nassour I; Mokdad AA; Porembka MR; Choti MA; Polanco PM; Mansour JC; Minter RM; Wang SC; Yopp AC
    Ann Surg Oncol; 2018 May; 25(5):1193-1201. PubMed ID: 29488187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrence after curative-intent resection of perihilar cholangiocarcinoma: analysis of a large cohort with a close postoperative follow-up approach.
    Komaya K; Ebata T; Yokoyama Y; Igami T; Sugawara G; Mizuno T; Yamaguchi J; Nagino M
    Surgery; 2018 Apr; 163(4):732-738. PubMed ID: 29336813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of adjuvant chemotherapy in patients with intrahepatic cholangiocarcinoma: a matched pair analysis.
    Schweitzer N; Weber T; Kirstein MM; Fischer M; Kratzel AM; Reineke-Plaaß T; Lehner F; Manns MP; Vogel A
    J Cancer Res Clin Oncol; 2017 Jul; 143(7):1347-1355. PubMed ID: 28314929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant chemotherapy in resectable cholangiocarcinoma patients.
    Wirasorn K; Ngamprasertchai T; Khuntikeo N; Pakkhem A; Ungarereevittaya P; Chindaprasirt J; Sookprasert A
    J Gastroenterol Hepatol; 2013 Dec; 28(12):1885-91. PubMed ID: 23829232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical treatment and adjuvant chemotherapy for patients with biliary tract cancer: single institution experience of 100 patients.
    Harada N; Shirabe K; Yoshizumi T; Ikegami T; Uchiyama H; Soejima Y; Yamashita Y; Saeki H; Oki E; Kawanaka H; Morita M; Ikeda T; Matsuura H; Okadome K; Maehara Y
    Fukuoka Igaku Zasshi; 2013 Dec; 104(12):539-48. PubMed ID: 24693682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gemcitabine Plus Cisplatin Chemotherapy Prolongs the Survival in Advanced Hilar Cholangiocarcinoma: A Large Multicenter Study.
    Shin DW; Kim MJ; Lee JC; Kim J; Woo SM; Lee WJ; Lee KH; Hwang JH
    Am J Clin Oncol; 2020 Jun; 43(6):422-427. PubMed ID: 32118610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.